INFUSION SITE SWELLING

This adverse event was reported 6299 times

These drugs are most commonly taken by patients reporting INFUSION SITE SWELLING:

# Drug Count
0 TREPROSTINIL 1939
1 HUMAN IMMUNOGLOBULIN G 1585
2 ACETAMINOPHEN 1114
3 DIPHENHYDRAMINE HYDROCHLORIDE 909
4 ACETAMINOPHEN 500MG 796
5 ACETAMINOPHEN TABLET EXTENDED RELEASE 796
6 PAIN RELIEVER 796
7 LIDOCAINE HYDROCHLORIDE 716
8 EPINEPHRINE 664
9 TADALAFIL 624
See all common drugs associated with INFUSION SITE SWELLING

INFUSION SITE SWELLING is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Human Immunoglobulin G [EPC] 1818 0.0863
1 Provitamin D2 Compound [EPC] 570 0.0192
2 Interleukin-5 Antagonist [EPC] 12 0.0174
3 Prostacycline Vasodilator [EPC] 1953 0.0142
4 Guanylate Cyclase-C Agonist [EPC] 26 0.0125
5 Amide Local Anesthetic [EPC] 882 0.0101
6 Antiarrhythmic [EPC] 883 0.0089
7 Vitamin B6 Analog [EPC] 3 0.0083
8 Catecholamine [EPC] 672 0.0082
9 Human alpha-1 Proteinase Inhibitor [EPC] 33 0.0078
See all drug classes enriched for association with INFUSION SITE SWELLING